Circulating Tumor Cells (CTC) predict survival benefit from treatment in metastatic castration resistant prostate cancer (CRPC)

J.S. de Bono, H.I. Scher, R.B. Montgomery, C. Parker, M.C. Miller, H. Tissing, G.V. Doyle, Leonardus Wendelinus Mathias Marie Terstappen, K.J. Pienta, D. Raghavan

    Research output: Contribution to journalArticleAcademicpeer-review

    1642 Citations (Scopus)
    Original languageUndefined
    Pages (from-to)6302-6309
    Number of pages8
    JournalClinical cancer research
    Publication statusPublished - 2008


    • METIS-251923

    Cite this